Advertisement

GI & Endoscopy

The payer-provider relationship can be contentious. Here are 11 statistics on how gastroenterologists plan to interact with payers this year, according to the Medscape Gastroenterologist Compensation Report 2014.

A recent study published in the journal Clinical Gastroenterology and Hepatology, outlines three ways gastroenterologists can demonstrate value in the new healthcare continuum.

Advertisement

The FDA has approved ledipasvir/sofosbuvir (Harvoni), a combination anti-viral drug for the treatment of the hepatitis C virus, according to a Medscape report.

CMS has issued its final National Coverage Determination for the colorectal cancer stool DNA test Cologuard, developed by Exact Sciences.

Advertisement